About the Journal

This page provides detailed information about the journal’s scope, policies, publishing practices, and governance.

About

Cancer Biome and Targeted Therapy (CBTT) publishes peer-reviewed, interdisciplinary research and reviews focused on the tumor microenvironment, microbial influences, immune dynamics, and mechanisms of resistance to cancer therapies.

Aims and Scope

Cancer Biome and Targeted Therapy is a peer-reviewed, open-access journal publishing high-quality, interdisciplinary research at the intersection of tumor biology, immunology, microbiology, and precision oncology. The journal advances understanding of the cancer biome, the complex biological and microbial ecosystem surrounding tumor cells, and its impact on cancer progression, immune modulation, therapeutic resistance, and clinical outcomes.

Cancer Biome and Targeted Therapy welcomes original research, reviews, and translational studies addressing key areas, including:

  • Oncology: Molecular and translational cancer research, tumor biology, disease progression, and therapeutic response.
  • Immunology: Immune tumor microenvironment and host–tumor interactions.
  • Microbiology: Microbial ecosystems, including bacterial, fungal, viral, and parasitic components, and their influence on the tumor niche.
  • Biochemistry & Molecular Biology: Molecular cancer mechanisms, signaling, biomarkers, diagnostics, and therapeutic targets.
  • Pharmacology and therapeutics: Resistance mechanisms and the development of precision and targeted therapies.
  • Molecular Medicine: Molecular and genetic mechanisms underlying cancer initiation, progression, and therapy response.

Co-Editors-in-Chief:

Antoine Italiano, MD, PhD; Ubaldo Martinez-Outschoorn, MD, PhD; Peng Huang, PhD.
Co-Editors-in-Chief, Editorial Board members' contact information is listed on the Editorial Board Team

Cancer Biome and Targeted Therapy uphold the highest standards of ethical open-access publishing, adhering to DOAJ and COPE guidelines while maintaining full editorial independence. 

Mission Statement

Cancer Biome and Targeted Therapy is committed to advancing a systems-level understanding of cancer by exploring the biological, immunological, microbial, and therapeutic dimensions of the tumor environment. Our mission is to provide an open-access platform for high-quality, peer-reviewed research that uncovers how the complex interplay between tumors and their surrounding ecosystems influences disease behavior, therapeutic resistance, and clinical outcomes.

Article Processing Charge (APC)

Cancer Biome and Targeted Therapy does not charge submission fees, page charges, or article processing charges (APCs). All accepted articles are published open access, at no cost to authors.

Instructions for authors

Detailed information on manuscript preparation, article types, submission requirements, peer review procedures, publication policies, and ethical standards is provided in the Instructions for Authors. View Instructions for Authors

Open Access

Under the open-access model, Cancer Biome and Targeted Therapy do not impose embargoes or subscription restrictions. All articles are made freely accessible immediately upon publication, providing readers with instant, unrestricted access to the content. All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). https://creativecommons.org/licenses/by/4.0/.

Publishing Frequency

Cancer Biome and Targeted Therapy is an international, peer-reviewed, open-access journal that publishes four regular issues per year, scheduled for February, May, August, and November. The inaugural issue may be published outside the regular schedule during the journal’s launch phase.

Language

English

 

About the Publisher 

The publisher of this journal is GCINC Press.

The publisher's offices are located in Spokane, Washington, United States.

Publisher Address:
GCINC Press 
522 W Riverside Ave, Suite N
Spokane, WA 99201
United States

Publisher Contact Email:
submissions@cancerbiometherapy.com

 

Open Journal System and Archival System

Cancer Biome and Targeted Therapy is hosted on the Open Journal Systems (OJS) platform, developed and maintained by the Public Knowledge Project (PKP) with daily backups, digital preservation, and archiving on the PKP Preservation Network (PKP PN) using the LOCKSS Program. Once an ISSN has been attributed, Cancer Biome and Targeted Therapy will, in addition to PKP PN, participate in the LOCKSS program to ensure long-term digital preservation.

Although the platform complies with relevant privacy and data protection regulations, including the British Columbia Freedom of Information and Protection of Privacy Act (FIPPA) and the European Union’s General Data Protection Regulation (GDPR), the journal does not control or guarantee the performance, availability, or security of the platform’s infrastructure. By using this website, users acknowledge and agree that the journal and its publisher shall not be held responsible for any damages or losses arising from platform-related failures or from external data-handling processes managed by PKP or its hosting providers.

Metadata Exposure and Repository Interoperability

In addition to digital preservation, Cancer Biome and Targeted Therapy supports standardized metadata dissemination through the Open Archives Initiative Protocol for Metadata Harvesting (OAI-PMH). Article-level metadata are made available for harvesting by libraries, institutional repositories, and indexing services, facilitating discovery, citation, and long-term accessibility of published content.

Self-Archiving Policy (For Accepted Manuscripts):

Authors are permitted and encouraged to post the accepted version (postprint) of their manuscript, after peer review but before final typesetting, in personal repositories, institutional archives, or recognized preprint servers. This policy applies to the accepted manuscript version and does not restrict the sharing of links to the final published version of record.

To preserve the integrity of the published record, authors should:

  • Clearly label the version as "Accepted Manuscript."
  • Include the DOI and citation to the final published version once available
  • Do not share the formatted publisher PDF without prior permission

This policy supports author visibility, compliance with funder requirements, and the broader goals of open science.

 

 

Last updated: November 2025